Evolent Health annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evolent Health's operating margin was −21.86% for fiscal 2025.
View full Evolent Health company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −21.86% | −20.27 pp |
| 2024 | 2024-12-31 | −1.58% | +2.04 pp |
| 2023 | 2023-12-31 | −3.63% | −3.90 pp |
| 2022 | 2022-12-31 | 0.27% | +4.94 pp |
| 2021 | 2021-12-31 | −4.67% | +23.76 pp |
| 2020 | 2020-12-31 | −28.43% | +8.07 pp |
| 2019 | 2019-12-31 | −36.49% | −28.92 pp |
| 2018 | 2018-12-31 | −7.57% | +9.17 pp |
| 2017 | 2017-12-31 | −16.75% | +76.66 pp |
| 2016 | 2016-12-31 | −93.40% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1.47% | −1.20 pp |
| Q1 2026 | 2026-03-31 | −2.14% | −1.80 pp |
| Q4 2025 | 2025-12-31 | −87.10% | −84.22 pp |
| Q3 2025 | 2025-09-30 | 0.18% | +2.80 pp |
| Q2 2025 | 2025-06-30 | −0.26% | −1.47 pp |
| Q1 2025 | 2025-03-31 | −0.34% | +1.76 pp |
| Q4 2024 | 2024-12-31 | −2.88% | +0.96 pp |
| Q3 2024 | 2024-09-30 | −2.62% | +0.89 pp |
| Q2 2024 | 2024-06-30 | 1.20% | +5.80 pp |
| Q1 2024 | 2024-03-31 | −2.10% | +0.32 pp |
| Q4 2023 | 2023-12-31 | −3.84% | −3.35 pp |
| Q3 2023 | 2023-09-30 | −3.51% | −7.18 pp |
| Q2 2023 | 2023-06-30 | −4.60% | −3.15 pp |
| Q1 2023 | 2023-03-31 | −2.42% | −1.48 pp |
| Q4 2022 | 2022-12-31 | −0.49% | +4.43 pp |
| Q3 2022 | 2022-09-30 | 3.67% | +6.63 pp |
| Q2 2022 | 2022-06-30 | −1.45% | +2.01 pp |
| Q1 2022 | 2022-03-31 | −0.94% | +6.47 pp |
| Q4 2021 | 2021-12-31 | −4.92% | −7.75 pp |
| Q3 2021 | 2021-09-30 | −2.96% | +3.26 pp |
| Q2 2021 | 2021-06-30 | −3.45% | +91.18 pp |
| Q1 2021 | 2021-03-31 | −7.41% | +2.90 pp |
| Q4 2020 | 2020-12-31 | 2.83% | +94.52 pp |
| Q3 2020 | 2020-09-30 | −6.22% | +2.93 pp |
| Q2 2020 | 2020-06-30 | −94.63% | −81.49 pp |
| Q1 2020 | 2020-03-31 | −10.31% | +13.28 pp |
| Q4 2019 | 2019-12-31 | −91.69% | −84.77 pp |
| Q3 2019 | 2019-09-30 | −9.15% | −1.79 pp |
| Q2 2019 | 2019-06-30 | −13.14% | −6.93 pp |
| Q1 2019 | 2019-03-31 | −23.59% | −13.47 pp |
| Q4 2018 | 2018-12-31 | −6.91% | +9.13 pp |
| Q3 2018 | 2018-09-30 | −7.36% | +5.64 pp |
| Q2 2018 | 2018-06-30 | −6.21% | +11.64 pp |
| Q1 2018 | 2018-03-31 | −10.11% | +10.08 pp |
| Q4 2017 | 2017-12-31 | −16.05% | — |
| Q3 2017 | 2017-09-30 | −12.99% | — |
| Q2 2017 | 2017-06-30 | −17.85% | — |
| Q1 2017 | 2017-03-31 | −20.20% | — |
Over the last five reported fiscal years, Evolent Health's operating margin increased from −28.43% to −21.86%, a change of +6.57 percentage points. The latest reported quarter, Q2 2026, shows −1.47%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evolent Health filings at SEC.gov ↗